A selective CD28 antagonist and rapamycin synergise to protect against spontaneous autoimmune diabetes in NOD mice

Overview of attention for article published in Diabetologia, May 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 44,695 followers.

RT @immunicom: Rapamycin and cd28 ligation prevent #diabetes in NOD model https://t.co/VIND2IkYIv

Reply Repost Favourite

RT @immunicom: Rapamycin and cd28 ligation prevent #diabetes in NOD model https://t.co/VIND2IkYIv

Reply Repost Favourite

Rapamycin and cd28 ligation prevent #diabetes in NOD model https://t.co/VIND2IkYIv

Reply Repost Favourite

Simultaneous blockade of #CD28 and #mTOR pathways (using selective CD28 antagonist and rapamycin) limits T cell activation and infiltration of pancreatic #islets and protects from #T1D development in #NODmice https://t.co/YG6VZj5VYa https://t.co/cF0xG6UYaP

Reply Repost Favourite